Venkataraghavan S, Pankow J, Boerwinkle E, Fornage M, Selvin E, Ray D
Diabetologia. 2025; .
PMID: 39971753
DOI: 10.1007/s00125-024-06352-9.
Guzman N, Letelier P, Morales C, Alarcon L, Delgado H, San Martin A
J Clin Med. 2024; 13(23).
PMID: 39685758
PMC: 11642720.
DOI: 10.3390/jcm13237300.
Bjarko V, Haug E, Langhammer A, Ruiz P, Carlsson S, Birkeland K
BMJ Open Diabetes Res Care. 2024; 12(6).
PMID: 39577876
PMC: 11590787.
DOI: 10.1136/bmjdrc-2024-004493.
Parsons R, Blythe R, Cramb S, Abdel-Hafez A, McPhail S
J Med Internet Res. 2024; 26:e59634.
PMID: 39536309
PMC: 11602763.
DOI: 10.2196/59634.
Reeves D, Morgan C, Stamate D, Ford E, Ashcroft D, Kontopantelis E
PLoS One. 2024; 19(10):e0310712.
PMID: 39365767
PMC: 11452046.
DOI: 10.1371/journal.pone.0310712.
Timing and Modality of Kidney Replacement Therapy in Children and Adolescents.
Thumfart J, Wagner S, Kirchner M, Azukaitis K, Bayazit A, Obrycki L
Kidney Int Rep. 2024; 9(9):2750-2758.
PMID: 39291215
PMC: 11403031.
DOI: 10.1016/j.ekir.2024.06.009.
Prospective Study on Kidney Dysfunction Markers and Risk for Mortality among South Asians.
Jagannathan R, Anand S, Kondal D, Han J, Montez-Rath M, Ali M
Kidney Int Rep. 2024; 9(8):2537-2545.
PMID: 39156172
PMC: 11328749.
DOI: 10.1016/j.ekir.2024.05.025.
Impacts of Nutlin-3a and exercise on murine double minute 2-enriched glioma treatment.
Chen Y, Fan Z, Luo Z, Kang X, Wan R, Li F
Neural Regen Res. 2024; 20(4):1135-1152.
PMID: 38989952
PMC: 11438351.
DOI: 10.4103/NRR.NRR-D-23-00875.
Elucidating Cancer Subtypes by Using the Relationship between DNA Methylation and Gene Expression.
Jilani M, Degras D, Haspel N
Genes (Basel). 2024; 15(5).
PMID: 38790260
PMC: 11121157.
DOI: 10.3390/genes15050631.
Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validation of a clinical risk prediction model.
Clift A, Tan P, Patone M, Liao W, Coupland C, Bashford-Rogers R
Br J Cancer. 2024; 130(12):1969-1978.
PMID: 38702436
PMC: 11183048.
DOI: 10.1038/s41416-024-02693-9.
Impact of serum leptin and adiponectin levels on brain infarcts in patients with mild cognitive impairment and Alzheimer's disease: a longitudinal analysis.
Carbone G, Bencivenga L, Santoro M, De Lucia N, Palaia M, Ercolano E
Front Endocrinol (Lausanne). 2024; 15:1389014.
PMID: 38686200
PMC: 11056582.
DOI: 10.3389/fendo.2024.1389014.
Evaluation of clinical prediction models (part 2): how to undertake an external validation study.
Riley R, Archer L, Snell K, Ensor J, Dhiman P, Martin G
BMJ. 2024; 384:e074820.
PMID: 38224968
PMC: 10788734.
DOI: 10.1136/bmj-2023-074820.
Machine Learning Models for Predicting Stroke Mortality in Malaysia: An Application and Comparative Analysis.
Che Nawi C, Mohd Hairon S, Wan Yahya W, Wan Zaidi W, Musa K
Cureus. 2024; 15(12):e50426.
PMID: 38222138
PMC: 10784718.
DOI: 10.7759/cureus.50426.
External validation of the QCovid 2 and 3 risk prediction algorithms for risk of COVID-19 hospitalisation and mortality in adults: a national cohort study in Scotland.
Kerr S, Millington T, Rudan I, McCowan C, Tibble H, Jeffrey K
BMJ Open. 2023; 13(12):e075958.
PMID: 38151278
PMC: 10753764.
DOI: 10.1136/bmjopen-2023-075958.
A prognostic model for ovarian neoplasms established by an integrated analysis of 1580 transcriptomic profiles.
Hua Y, Cai D, Shirley C, Mo S, Chen R, Gao F
Sci Rep. 2023; 13(1):19429.
PMID: 37940688
PMC: 10632395.
DOI: 10.1038/s41598-023-45410-x.
Generation and validation of a predictive model for estimating survival among patients with EGFR-mutant non-small cell lung cancer.
Lin C, Chou Y, Su P, Lin C, Chang J, Huang C
Am J Cancer Res. 2023; 13(9):4208-4221.
PMID: 37818047
PMC: 10560933.
Prognostic models for clinical outcomes in patients with venous leg ulcers: A systematic review.
Velickovic V, Macmillan T, Kottner J, Crompton A, Munro I, Paine A
J Vasc Surg Venous Lymphat Disord. 2023; 12(1):101673.
PMID: 37689364
PMC: 11523447.
DOI: 10.1016/j.jvsv.2023.06.017.
Development and validation of a novel risk prediction algorithm to estimate 10-year risk of oesophageal cancer in primary care: prospective cohort study and evaluation of performance against two other risk prediction models.
Hippisley-Cox J, Mei W, Fitzgerald R, Coupland C
Lancet Reg Health Eur. 2023; 32:100700.
PMID: 37635924
PMC: 10450987.
DOI: 10.1016/j.lanepe.2023.100700.
Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank.
Parsons R, Liu X, Collister J, Clifton D, Cairns B, Clifton L
Heart. 2023; 109(22):1690-1697.
PMID: 37423742
PMC: 10646868.
DOI: 10.1136/heartjnl-2022-321231.
More efficient and inclusive time-to-event trials with covariate adjustment: a simulation study.
Momal R, Li H, Trichelair P, Blum M, Balazard F
Trials. 2023; 24(1):380.
PMID: 37280655
PMC: 10245605.
DOI: 10.1186/s13063-023-07375-0.